Weight Management
BATCH 04-26 · LIVELAB-VERIFIED01 / 01
Tirzepatide·Research-grade peptide
Tirzepatide
Dual GIP/GLP-1 agonist
Dual-agonist research peptide engaging both GIP and GLP-1 receptors for metabolic research.
Purity
99%
Weight
10 mg
Half-life
—
Route
—
10mg vial · 10 mg
$80
Tirzepatide
✓ In stock
1
↻ Subscribe coming soonFree shipping from $250
RX. SUGGESTED PROTOCOL
Tirzepatide is a dual agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. The dual-pathway engagement supports investigation of insulin secretion, glucose metabolism, and obesity research models.
CYCLE
—
ROUTE
—
For research use only.
Intended strictly for in-vitro research and laboratory use. Not for human consumption. Not evaluated by the FDA. No statements on this page are intended to diagnose, treat, cure, or prevent any disease.
FROM THE CATALOGPairs well with
